Edition:
India

Catabasis Pharmaceuticals Reports Q4 Loss Per Share Of $0.85


Thursday, 14 Mar 2019 

March 14 (Reuters) - Catabasis Pharmaceuticals Inc ::CATABASIS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS.Q4 LOSS PER SHARE $0.85.Q4 EARNINGS PER SHARE ESTIMATE $-0.90 -- REFINITIV IBES DATA.AS OF DECEMBER 31, 2018, CATABASIS HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $37.6 MILLION. 

Company Quote

4.76
0.0 +0.00%
16 Oct 2019